Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, December 22, 2016

Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients



open access

 METHODS
For this prospective cohort study, 55 female patients were recruited from two cancer treatment centres in Germany and Switzerland starting in 2013 to the end of 2014. The study was approved by the corresponding ethics commission (reference no. 01.53.01).
All consecutive cancer patients 18 years of age and older who planned to undergo neoadjuvant or adjuvant chemotherapy for breast, endometrial, or ovarian cancer were assessed for enrolment in the study....

 CONCLUSIONS
Results from studies of the array of scalp cooling systems designed to prevent chemotherapy-induced alopecia, a common and psychologically troubling side effect for cancer patients, have varied. Our research showed that the effectiveness of DigniCap, a sensor-controlled scalp cooling system, depends on the chemotherapy regimen and the patient’s age. Because subjective and objective indicators of success often differ, we recommend the use of a compound endpoint to gain more insightful and practical information to use in counselling patients.

 

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.